Tag: Semarion
-
Semarion raises $3.8M to scale cell assay technology
Semarion, a University of Cambridge spin-out from the Cavendish Laboratory, has raised $3.8 million in funding to support the expansion of its cell-based screening technology. The round was led by Parkwalk, with participation from The FSE Group, Cambridge Enterprise Ventures, Oxford Innovation Finance, Found Capital, Cambridge Capital Group, and Start Codon. This round follows the read more
Written by
